About this item:

51 Views | 24 Downloads

Author Notes:

miavanderkop@gmail.com

Conceived and designed the experiments: RL CM MvdK LT LG. Analyzed the data: MvdK. Wrote the paper: MvdK. Performed the data collection: SK. Supervised the data collection: RTL. Data interpretation: MvdK RTL CM JK MC. Revised the manuscript critically for intellectual content: RTL CM LT MC SK JK and LG. Approved the final manuscript submitted for publication: MvdK SK LT CM MC LG JK RL.

Richard T. Lester is the founder of WelTel, a non-profit non-governmental mHealth organization. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

We thank the healthcare staff and patients who participated in the study. The findings and conclusions in this paper are those of the authors and do not necessarily reflect those of the funding agencies.

Subjects:

Research Funding:

The original trial was funded by the United States President’s Emergency Plan for AIDS Relief (PEPFAR) through the Centre for Disease Control (CDC) cooperative agreement 5U62PS024510 as a public-health evaluation (PHE:KE07.0045). No additional funding was secured to conduct this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Keywords:

  • Science & Technology
  • Multidisciplinary Sciences
  • Science & Technology - Other Topics
  • RANDOMIZED CONTROLLED-TRIAL
  • HIV-1-INFECTED PATIENTS
  • THERAPY
  • SYSTEM
  • SUPPORT

In-Depth Analysis of Patient-Clinician Cell Phone Communication during the WelTel Kenya1 Antiretroviral Adherence Trial

Tools:

Journal Title:

PLOS ONE

Volume:

Volume 7, Number 9

Publisher:

, Pages e46033-e46033

Type of Work:

Article | Final Publisher PDF

Abstract:

Background: The WelTel Kenya1 trial demonstrated that text message support improved adherence to antiretroviral therapy (ART) and suppression of HIV-1 RNA load. The intervention involved sending weekly messages to patients inquiring how they were doing; participants were required to respond either that they were well or that there was a problem. Objectives: 1) Describe problems participants identified through mobile phone support and reasons why participants did not respond to the messages; 2) investigate factors associated with indicating a problem and not responding; and 3) examine participant perceptions of the intervention. Design: Secondary analysis of WelTel Kenya1 trial data. Methods: Reasons participants indicated a problem or did not respond were extracted from the study log. Negative binomial regression was used to determine participant characteristics associated with indicating a problem and non-response. Data from follow-up questionnaires were used to describe participant perceptions of the intervention. Results: Between 2007 and 2009, 271 participants generated 11,873 responses; 377 of which indicated a problem. Health issues were the primary reason for problem responses (72%). Rural residence (adjusted incidence rate ratio [IRR] 1.96; 95%CI 1.19-3.25; p = 0.009 and age were associated with indicating a problem (adjusted IRR 0.63 per increase in age group category; 95%CI 0.50-0.80; p<0.001). Higher educational level was associated with a decreased rate of non-response (adjusted IRR 0.81; 95%CI 0.69-0.94; p = 0.005). Of participants interviewed, 62% (n = 129) stated there were no barriers to the intervention; cell phone issues were the most common barrier. Benefits included reminding patients to take medication and promoting a feeling that "someone cares". Conclusions: The WelTel intervention enabled frequent communication between clinicians and patients during the WelTel Kenya1 trial. Many patients valued the service for the support it provided, with health-related concerns comprising the majority of problems identified by participants. Few sociodemographic characteristics were associated with participant engagement in the intervention.

Copyright information:

© 2012 van der Kop et al.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/rdf).
Export to EndNote